GI symptom rates at the 12 mg dose included nausea (38-43%), diarrhea (33-35%), constipation (21-25%), and vomiting (20-21%)
The Precision Peptide Genetic Test reads 14 pathways, 49 peptides, 150+ genetic insights so that context comes first
Is the Retatrutide starting dose the same for weight loss and diabetes
Healthcare providers carefully evaluate each patient's situation, considering factors such as comorbid conditions and medication interactions
Over 40% of GLP-1 users experience nausea at some point, and switching between medications can trigger a new round of GI adjustment even in people who had fully adapted to their previous medication
Svalheim S, Sveberg L, Mochol M, Taubll E (2015) Interactions between antiepileptic drugs and hormones